Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V V Baker

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Gynecologic Oncology|April 1, 1997
Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-AC A Bergman, F Talavera, G M Christman, et al.
Gynecologic Oncology|September 1, 1990
Oncogene alterations in endometrial carcinomaM P Borst, V V Baker, D Dixon, et al.
Obstetrics and Gynecology Clinics of North America|June 1, 1996
Endometrial hyperplasia and endometrial cancerT W Burke, G Tortolero-Luna, A Malpica, et al.
Gynecologic Oncology|March 22, 2003
Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cellsA R Munkarah, Z Genhai, R Morris, et al.
Obstetrics and Gynecology Clinics of North America|June 1, 1996
Ovarian intraepithelial neoplasia and ovarian cancerD M Gershenson, G Tortolero-Luna, A Malpica, et al.
Obstetrics and Gynecology|June 1, 1989
Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervixH M Shingleton, S J Soong, M S Gelder, et al.
Gynecologic Oncology|October 1, 1994
Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinomaT W Burke, D M Gershenson, M Morris, et al.
Selective Cancer Therapeutics|January 1, 1991
Detection of P-glycoprotein with JSB-1 monoclonal antibody in B-5 fixed and paraffin-embedded cell lines and tissuesZ P Pavelic, Z Sever, R N Fontaine, et al.
Obstetrics and Gynecology Clinics of North America|June 1, 1996
Uterine sarcomaC F Levenback, G Tortolero-Luna, D K Pandey, et al.
Obstetrics and Gynecology Clinics of North America|June 1, 1996
Gestational trophoblastic diseaseR S Freedman, G Tortolero-Luna, D K Pandey, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Gynecologic Oncology|April 1, 1997
Transforming growth factor-beta negatively modulates proliferation and c-fos expression of the human endometrial adenocarcinoma cell line HEC-1-AC A Bergman, F Talavera, G M Christman, et al.
Gynecologic Oncology|September 1, 1990
Oncogene alterations in endometrial carcinomaM P Borst, V V Baker, D Dixon, et al.
Obstetrics and Gynecology Clinics of North America|June 1, 1996
Endometrial hyperplasia and endometrial cancerT W Burke, G Tortolero-Luna, A Malpica, et al.
Gynecologic Oncology|March 22, 2003
Inhibition of paclitaxel-induced apoptosis by the specific COX-2 inhibitor, NS398, in epithelial ovarian cancer cellsA R Munkarah, Z Genhai, R Morris, et al.
Obstetrics and Gynecology Clinics of North America|June 1, 1996
Ovarian intraepithelial neoplasia and ovarian cancerD M Gershenson, G Tortolero-Luna, A Malpica, et al.
Obstetrics and Gynecology|June 1, 1989
Clinical and histopathologic factors predicting recurrence and survival after pelvic exenteration for cancer of the cervixH M Shingleton, S J Soong, M S Gelder, et al.
Gynecologic Oncology|October 1, 1994
Postoperative adjuvant cisplatin, doxorubicin, and cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinomaT W Burke, D M Gershenson, M Morris, et al.
Selective Cancer Therapeutics|January 1, 1991
Detection of P-glycoprotein with JSB-1 monoclonal antibody in B-5 fixed and paraffin-embedded cell lines and tissuesZ P Pavelic, Z Sever, R N Fontaine, et al.
Obstetrics and Gynecology Clinics of North America|June 1, 1996
Uterine sarcomaC F Levenback, G Tortolero-Luna, D K Pandey, et al.
Obstetrics and Gynecology Clinics of North America|June 1, 1996
Gestational trophoblastic diseaseR S Freedman, G Tortolero-Luna, D K Pandey, et al.
Pageof 6